Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02270866 · ClinicalTrials.gov registry record · NA
Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia
A NA study, sponsored by Scion NeuroStim.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02270866: Completed NA study, sponsored by Scion NeuroStim.
NCT02270866 is a NA study that has completed, run by Scion NeuroStim. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02270866, a NA study, has completed, sponsored by Scion NeuroStim.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a single site, open label study with a single arm designed to assess the feasibility of use of caloric vestibular stimulation (CVS) in patients with post-stroke aphasia. CVS is delivered via a portable, non-invasive device. Both language and movement assessments are made.
Primary Outcome
At the end of the 84 day period of device use, the patient's verbal fluency will be compared with the baseline level to assess any improvement. Boston Diagnostic Aphasia exam, Hopkins verbal learning test, oral symbol digit modality test, oral trail marking test.
Interventions
- DEVICE TNM Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT02270866 record still lists
NCT02270866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which TNM Device is the first listed.
NCT02270866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02270866 about?
NCT02270866 is a clinical study titled "Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia". This is a single site, open label study with a single arm designed to assess the feasibility of use of caloric vestibular stimulation (CVS) in patients with post-stroke aphasia. CVS is delivered via a portable, non-invasive device. Both language and movement assessments are made.
What is the current status of trial NCT02270866?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2014-10. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02270866?
The interventions under investigation include: TNM Device (DEVICE).
Who is sponsoring clinical trial NCT02270866?
This trial is sponsored by Scion NeuroStim, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02270866's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia